AI & ChatGPT searches , social queries for SHULGIN
Search references for SHULGIN. Phrases containing SHULGIN
See searches and references containing SHULGIN!
Search references for SHULGIN. Phrases containing SHULGIN
See searches and references containing SHULGIN!SHULGIN
American chemist and recreational drug explorer (1925–2014)
Alexander Theodore "Sasha" Shulgin (June 17, 1925 – June 2, 2014) was an American biochemist who synthesized and tested over 200 psychedelic and related
Alexander_Shulgin
Surname list
developer Shulgin Rating Scale Alexander Shulgin (musician) (born 1964), Russian author and composer Alexei Shulgin (born 1963), Russian artist Ann Shulgin (1931–2022)
Shulgin
Book about phenethylamines
The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds is a 2011 book written by Alexander Shulgin, Tania Manning, and Paul F
The_Shulgin_Index
American author (1931–2022)
Laura Ann Shulgin (née Gotlieb; March 22, 1931 – July 9, 2022) was an American author and the wife of chemist Alexander Shulgin, with whom she wrote the
Ann_Shulgin
Topics referred to by the same term
Shulgin (1925–2014) was an American chemist. Alexander Shulgin (Russian: Алекса́ндр Шульги́н) and related names may also refer to: Alexander Shulgin (musician)
Alexander Shulgin (disambiguation)
Alexander_Shulgin_(disambiguation)
Psychedelic drug
2C-B-FLY, and 25B-NBOMe among others. 2C-B was developed by Alexander Shulgin in 1974 and was described by him in the scientific literature in 1975.
2C-B
Topics referred to by the same term
Sergei Shulgin may refer to: Sergei Shulgin (footballer) Sergei Shulgin (politician) This disambiguation page lists articles about people with the same
Sergei_Shulgin
Scale for reporting subjective effects of psychoactive substances
The Shulgin Rating Scale (or "quantitative potency scale") is a simple scale for reporting the subjective effect of psychoactive substances at a given
Shulgin_Rating_Scale
Russian politician (1878–1976)
Vasily Vitalyevich Shulgin (Russian: Васи́лий Вита́льевич Шульги́н; 13 January 1878 – 15 February 1976), also known as Basil Shulgin, was a Russian conservative
Vasily_Shulgin
Russian e-commerce company
bookstore Litres. The current chief executive officer of Ozon is Alexander Shulgin, who joined the company after serving as chief financial officer and later
Ozon
Russian contemporary artist
Alexei Shulgin (Russian: Алексей Шульгин; born 1963 in Moscow) is a Russian born contemporary artist, musician, and online curator. Working out of Moscow
Alexei_Shulgin
bibliography, or list of publications, of the psychedelic chemist Alexander Shulgin. Shulgin AT (1988). The Controlled Substances Act: A Resource Manual of the
Bibliography of Alexander Shulgin
Bibliography_of_Alexander_Shulgin
Russian author and composer (born 1964)
Alexander Valeryevich Shulgin (born August 25, 1964) is a Russian author[citation needed] and composer. He was born in Irkutsk, Russia, and currently
Alexander_Shulgin_(musician)
1997 book by Alexander Shulgin and Ann Shulgin
Tryptamines I Have Known and Loved, is a 1997 book written by Alexander Shulgin and Ann Shulgin. It is about a family of psychoactive drugs known as tryptamines
TiHKAL
Chemical compound
analogue of methylethyltryptamine (MET). 4-HO-MET was discovered by Alexander Shulgin in the 1970s. It was first described in the literature by David Repke and
4-HO-MET
Pharmaceutical compound
originally named by Alexander Shulgin as described in his book PiHKAL (Phenethylamines I Have Known and Loved). Shulgin listed its dose as perhaps 100 mg
2C-Se
1991 book by Alexander Shulgin and Ann Shulgin
Phenethylamines I Have Known and Loved, is a book by Alexander Shulgin and Ann Shulgin published in 1991. The subject of the work is psychoactive phenethylamine
PiHKAL
psilocybin analogues Alexander Shulgin – developed numerous psychedelic phenethylamines and tryptamines Alexander Shulgin Research Institute (ASRI; Nicholas
List_of_psychedelic_chemists
Class of psychoactive drugs that produce empathic experiences
after. Gordon Alles discovered the psychoactive effects of MDA, Alexander Shulgin played a key role in bringing awareness to MDMA and its unique effects
Entactogen
Family of phenethylamine psychedelics
acting compounds. Most of the early 2C drugs were developed by Alexander Shulgin in the 1970s and 1980s and were reviewed in his 1991 book PiHKAL (Phenethylamines
2C_(psychedelics)
Pharmaceutical compound
(4C-D), among others. DOM was first synthesized and tested by Alexander Shulgin in 1963 and was later further described in his 1991 book PiHKAL (Phenethylamines
2,5-Dimethoxy-4-methylamphetamine
2,5-Dimethoxy-4-methylamphetamine
Pharmaceutical compound
(Phenethylamines I Have Known and Loved), Alexander Shulgin lists EEM's dose and duration as unknown. Shulgin stated that EEM has never been tested in humans
EEM_(drug)
Alexander Shulgin Research Institute (ASRI) is an organization developing novel psychedelic and entactogen drugs as potential pharmaceuticals, among other
Alexander Shulgin Research Institute
Alexander_Shulgin_Research_Institute
Species of cactus
effects at levels of 25 mg. Shulgin 1973 cited Shulgin, 1967 (Unpublished data) No effects in man. Shulgin 1976 cited Shulgin 1973 N-Methylmescaline has
Pachycereus_pringlei
Entactogen drug
III and Alexander Shulgin in the mid-1990s and was first described in the literature in 1996. It was patented by Jacob and Shulgin as a potential antidepressant
Methylone
Pharmaceutical compound
is taken orally. 2C-I was first synthesized and described by Alexander Shulgin in 1977 and was described in further detail in his 1991 book PiHKAL (Phenethylamines
2C-I
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists TMA-6's dose as 25 to 50 mg orally and its duration as 12 to 16 hours
2,4,6-Trimethoxyamphetamine
Pharmaceutical compound
(Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2C-G-5's dose as 10 to 16 mg orally and its duration as 32 to 48 hours
2C-G-5
Selo in Altai Krai, Russia
Shulgin Log (Russian: Шульгин Лог) is a rural locality (a selo) in Shulgin-Logsky Selsoviet, Sovetsky District, Altai Krai, Russia. The population was
Shulgin_Log
Russian footballer
Sergei Aleksandrovich Shulgin (Russian: Серге́й Александрович Шульгин; born 22 February 1963) is a former Russian professional footballer. He made his
Sergei_Shulgin_(footballer)
Psychedelic drug
toad). In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists 5-MeO-DMT's dose as 6 to 20 mg smoked or 2 to 3 mg by intravenous
5-MeO-DMT
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists Aleph-7's dose as 4 to 7 mg orally and its duration as 15 to 30 hours
Aleph-7
Psychedelic drug
by Alexander Shulgin in the 1960s and was described in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). Alexander Shulgin listed the dose
DMMDA
Pharmaceutical compound
described in the scientific literature by Alexander Shulgin and colleagues in 1991. Shortly after this, Shulgin described 2C-T-17 in greater detail in his 1991
2C-T-4
Group of psychedelic drugs
scientific literature by Alexander Shulgin via personal communication with Lemaire in the 1990s and 2000s. It was said by Shulgin in 2003 that the propoxy analogues
TWEETIO
Psychoactive drug
Ariadne was first synthesized by Alexander Shulgin in 1968 and its psychoactive effects were discovered by Shulgin in 1969. It was developed as a potential
Ariadne_(drug)
Common name for more than 1,000 species of flowering plants in the family Convolvulaceae
281–293. doi:10.1016/j.forsciint.2015.02.011. PMID 25747328. Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California:
Morning_glory
Pharmaceutical compound
(Phenethylamines I Have Known and Loved), Alexander Shulgin lists EME's dose and duration as unknown. Shulgin stated that EME has never been tested in humans
EME_(drug)
Pharmaceutical compound
the scientific literature by Alexander Shulgin in 1964. Subsequently, it was described in greater detail by Shulgin in his 1991 book PiHKAL (Phenethylamines
2,3,4-Trimethoxyamphetamine
Pharmaceutical compound
(Phenethylamines I Have Known and Loved), Alexander Shulgin lists EEE's dose and duration as unknown. Shulgin stated that EEE has never been tested in humans
EEE_(drug)
Entactogen drug
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MMDA's dose as 100 to 250 mg orally and its duration as "moderate"
MMDA_(drug)
Stimulant drug
drug of the substituted benzylamine group. It was reported by Alexander Shulgin in his book PIHKAL as a positional isomer of MDMA. Subsequently, the drug
M-ALPHA
Pharmaceutical compound
(4-isopropylthio-2,5-dimethoxyphenethylamine). According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved), Ψ-2C-T-4 produced
Ψ-2C-T-4
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists 2,4-DMA's dose as greater than 60 mg orally and its duration as "short"
2,4-Dimethoxyamphetamine
Pharmaceutical compound
(2C-G-0) 2C-G-5 and 2C-G-N Ganesha and G-3 5-APDI (IAP) DMMDA Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley
2C-G-3
Class of chemical compounds
its very high potency and its toxicity in overdose. 2C-B-FLY was Ann Shulgin's favorite psychedelic. Several of the FLY drugs have been shown to act
FLY_(psychedelics)
Psychedelic drug
DiPT in humans were described by Alexander Shulgin in 1976 and its effects were described in detail by Shulgin in subsequent publications in the 1980s and
DiPT
Russian volleyball player (born 1983)
Maxim Shulgin (born 17 May 1983) is a Russian volleyball player, a member of Russia men's national volleyball team and Russian club Lokomotiv Novosibirsk
Maxim_Shulgin
Pharmaceutical compound
scientific literature by Alexander Shulgin and Peyton Jacob III in 1983. Subsequently, it was also described by Shulgin in his 1991 book PiHKAL (Phenethylamines
2C-5-TOET
American researcher
Jacob extensively collaborated with and was close friends with Alexander Shulgin, including being part of his research group self-testing new psychedelic
Peyton_Jacob_III
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists Aleph's dose range as 5 to 10 mg orally and its duration as 6 to
Aleph_(psychedelic)
Class of chemical compounds
and DOx drugs. 4C drugs have been developed and/or studied by Alexander Shulgin, Daniel Trachsel, and Michael Cunningham and colleagues. Various other
4C_(psychedelics)
Pharmaceutical compound
literature by Alexander Shulgin and colleagues by at least 1967. Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991. 3,4-DMA
3,4-Dimethoxyamphetamine
Nonprofit educational organization
Hofmann collection, the Myron Stolaroff Collection, documents from Alexander Shulgin, and a complete archived snapshot of The Hive. Due to the subject matter
Erowid
Pharmaceutical compound
was included by Alexander Shulgin as an entry in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). However, Shulgin was unable to complete the
2C-G-4
Chemical compound
by 1976. Its effects in humans were assessed and reported by Alexander Shulgin in the 1980s and 1990s. The drug was encountered as a novel recreational
ETH-LAD
Psychedelic phenthylamine drug
was developed by Alexander Shulgin and colleagues and was described in greater detail by them in 1991, including in Shulgin's book PiHKAL (Phenethylamines
2C-T-7
Chemical compound
with Shulgin. 2CD-5EtO is a controlled substance in Canada under phenethylamine blanket-ban language. TWEETIO (psychedelics) Iris (DOM-5ETO) Shulgin A,
2CD-5EtO
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDPR's minimum dose as 200 mg orally and its duration as unknown
3,4-Methylenedioxy-N-propylamphetamine
3,4-Methylenedioxy-N-propylamphetamine
Substituted amphetamine psychedelic drug
described in the literature by Alexander Shulgin in 1970. Subsequently, it was described in greater detail by Shulgin in his 1991 book PiHKAL (Phenethylamines
2,5-Dimethoxy-4-butylamphetamine
2,5-Dimethoxy-4-butylamphetamine
Pharmaceutical compound
and allylescaline. Methallylescaline was first described by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). It was
Methallylescaline
Chemical compound
synthesized and described by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose of EiPT as 24 to 40 mg
Ethylisopropyltryptamine
Chemical compound
drug of the amphetamine family. MDPH was first synthesized by Alexander Shulgin. Very little data exists about the pharmacological properties, metabolism
3,4-Methylenedioxyphentermine
Pharmaceutical compound
the serotonin 5-HT2A receptor. 2C-E was first synthesized by Alexander Shulgin in 1977 and was documented in his 1991 book PiHKAL (Phenethylamines I Have
2C-E
Russian footballer
Aleksei Borisovich Shulgin (Russian: Алексей Борисович Шульгин; born 2 June 1997) is a Russian football player. He made his debut in the Russian Football
Aleksei_Shulgin_(footballer)
Pharmaceutical compound
is said to be very sparse. According to Shulgin, it produced threshold effects or a "plus-one" on the Shulgin Rating Scale at a dose of 80 mg orally,
2,5-Dimethoxyamphetamine
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists Aleph-6's dose as greater than 40 mg orally and its duration as "probably
Aleph-6
Psychedelic drug
orally. The drug has been encountered as a novel designer drug. Alexander Shulgin included 5-MeO-DPT in a subsection in the 5-MeO-DET entry of his book TiHKAL
5-MeO-DPT
Psychedelic drug
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists DMMDA-2's dose as about 50 mg orally and its duration as unknown
DMMDA-2
Pharmaceutical compound
scientific literature by Alexander Shulgin and colleagues in 1975. Subsequently, it was described in greater detail by Shulgin in his 1991 book PiHKAL (Phenethylamines
2,5-Dimethoxy-4-amylamphetamine
2,5-Dimethoxy-4-amylamphetamine
Class of chemical compounds
literature by Alexander Shulgin, Peyton Jacob III, and Darrell Lemaire in 1985. They were subsequently further described by Shulgin in his 1991 book PiHKAL
BOx_(psychedelics)
President of Russia (2000–2008; since 2012)
Pobedonostsev Putin Rodzianko Rogozin Rostopchin Rutskoy Sadovnichiy Shpak Shulgin Skokov Slutsky Stolypin Surkov Tolstoy (Dmitry) Tolstoy (Pyotr) Tyutchev
Vladimir_Putin
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists 2C-T-15's dose as greater than 30 mg orally and its duration as "several
2C-T-15
Pharmaceutical compound
first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists BOB's dose range as 10 to
BOB_(psychedelic)
Pharmaceutical compound
psychedelic phenethylamine of the 2C family. First synthesized by Alexander Shulgin, it has structural and pharmacodynamic properties similar to 2C-D and Ganesha
2C-G
Class of chemical compounds
of DOM from Shulgin. It is unclear why Shulgin provided information about DOM to Stanley, since doing so had the potential to risk Shulgin's professional
DOx
Drug belonging to the tryptamine class
effective as an antidepressant in preliminary clinical studies. Alexander Shulgin has said that 4-Me-αMT produced some feelings of unreality at 20 mg, as
4-Methyl-α-methyltryptamine
Pharmaceutical compound
described in the scientific literature by Shulgin in 1964. Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991. Substituted
MEDA
Pharmaceutical compound
scientific literature by Alexander Shulgin and colleagues in 1969. It was subsequently described in greater detail by Shulgin in his 1991 book PiHKAL (Phenethylamines
DME_(drug)
Pharmaceutical compound
literature by 1960. It was included as an entry in Alexander Shulgin's 2011 book The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related
3,4-Dimethylphenethylamine
Psychedelic drug
scientific literature by Alexander Shulgin by 1968. In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MEM's dose as 20 to 50 mg
2,5-Dimethoxy-4-ethoxyamphetamine
2,5-Dimethoxy-4-ethoxyamphetamine
Class of chemical compounds
characterized by Alexander Shulgin and described in his books such as PiHKAL (Phenethylamines I Have Known and Loved) and The Shulgin Index, Volume One: Psychedelic
Scaline
Pharmaceutical compound
Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved). He lists its dose as greater than 80 mg orally and its duration as unknown. Shulgin describes
MMDA-3b
Pharmaceutical compound
group at the α position of the side chain. In his book PiHKAL, Alexander Shulgin lists AEM's dose as greater than 220 mg orally and its duration as unknown
Α-Ethylmescaline
Pharmaceutical compound
his 1991 book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin described testing 4C-I at doses of up to 4 mg orally, but observed no effects
4C-I
Pharmaceutical compound
(Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 5-TASB's dose as approximately 160 mg orally and its duration as
5-Thioasymbescaline
Pharmaceutical compound
activity of DOM in humans, with a dose in the 10 to 15 mg range (Shulgin and Shulgin 1991). By contrast, the 2-butyl homolog was about one-third less
2,5-Dimethoxy-4-isobutylamphetamine
2,5-Dimethoxy-4-isobutylamphetamine
Pharmaceutical compound
Alexander Shulgin in PiHKAL in 1991. It is a controlled substance in Canada under phenethylamine blanket-ban language. In Alexander Shulgin's book PiHKAL
G-N_(drug)
Pharmaceutical compound
published 28 November 2024, assigned to Alexander Shulgin Research Institute Joe Moore (2 April 2024). "Shulgin Farm and the Future of Psychedelic Drug Development
ASR-2001
Pharmaceutical compound
Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved. While 2C-EF was briefly mentioned by Alexander Shulgin in his book
2C-EF
Class of psychoactive drugs
OCLC 858805226. Archived from the original on 21 August 2025. Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley
Substituted methylenedioxyphenethylamine
Substituted_methylenedioxyphenethylamine
Pharmaceutical compound
literature by Shulgin in PiHKAL in 1991. It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin. The drug
2CD-2,5-DiEtO
Pharmaceutical compound
including of the serotonin 5-HT2A receptor. 2C-T-2 was discovered by Alexander Shulgin in 1981 and was first described in the scientific literature by Myron Stolaroff
2C-T-2
Pharmaceutical compound
and Loved), Alexander Shulgin lists MDBZ's dose as greater than 150 mg orally and its duration as unknown. According to Shulgin, MDBZ showed "little if
Methylenedioxybenzylamphetamine
Methylenedioxybenzylamphetamine
Psychoactive drug, often called ecstasy
"Alexander 'Sasha' Shulgin". Alexander Shulgin Research Institute. Archived from the original on 20 December 2014. Retrieved 8 January 2015. Shulgin AT, Nichols
MDMA
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists Aleph-2's dose as 4 to 8 mg orally and its duration as 8 to 16 hours
Aleph-2
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists TMA-2's dose as 20 to 40 mg orally and its duration as 8 to 12 hours
2,4,5-Trimethoxyamphetamine
Pharmaceutical compound
(IDA) 3,4-Dimethoxyamphetamine (DMA) Shulgin A, Manning T, Daley PF (2011). "#65. EDA". The Shulgin Index, Volume One: Psychedelic Phenethylamines
3,4-Ethylenedioxyamphetamine
Chemical compound
described by David Repke and Alexander Shulgin and colleagues in 1985. It was subsequently further described by Shulgin in his 1997 book TiHKAL (Tryptamines
4-MeO-MiPT
Pharmaceutical compound
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists TMA's dose as 100 to 250 mg orally and its duration as 6 to 8 hours
3,4,5-Trimethoxyamphetamine
SHULGIN
SHULGIN
SHULGIN
SHULGIN
SHULGIN
SHULGIN
SHULGIN
SHULGIN
SHULGIN